Results 111 to 120 of about 19,606 (245)
Modified belt loop technique for scleral fixation of intraocular lenses. [PDF]
Wang L, Cui L, Jin H.
europepmc +1 more source
ABSTRACT Objective To determine longitudinal changes in chromatic pupillary light reflexes (cPLR) and retinal layers in dogs with sudden acquired retinal degeneration syndrome (SARDS). Animals Studied Clinical evaluation: Fifteen SARDS‐affected and nine control dogs.
Soohyun Kim +6 more
wiley +1 more source
Phakic Intraocular Lenses as a Potential Treatment for Pigment Dispersion Syndrome. [PDF]
Hirabayashi M +8 more
europepmc +1 more source
A thermo‐responsive poly(2‐oxazoline)‐based injectable formulation is developed to modulate intraocular pressure (IOP) in both normal and hypotonic eyes. By adjusting the PEG content, the aggregation behavior is finely tuned, enabling IOP elevation without long‐term deposition.
Yuji Tanaka +2 more
wiley +1 more source
Long-term astigmatism reduction with toric intraocular lenses: systematic review. [PDF]
Lam CC +5 more
europepmc +1 more source
Catechol‐functionalized cellulose hydrogels are developed as injectable, bioadhesive platforms for retinal neuroprotection. The hydrogels exhibit tunable rheological and mechanical properties, strong tissue adhesion, and sustained antioxidative activity.
Kai‐Hsiang Chang +4 more
wiley +1 more source
A comparative study of extended depth of focus, bifocal intraocular lenses and their mix-and-match. [PDF]
Fan F, Zhou XY, Yang JN, Liu X, Luo Y.
europepmc +1 more source
ABSTRACT Background and Aims Transfusion‐dependent beta‐thalassemia is a chronic hematologic disorder necessitating lifelong blood transfusions and iron chelation therapy, which can lead to systemic and ocular complications. This study aimed to assess the frequency and characteristics of ocular complications in beta‐thalassemia patients treated with ...
Abdolreza Medghalchi +7 more
wiley +1 more source
Segmentation Errors of Two Modern Biometers in 100 Eyes with Phakic Intraocular Lenses. [PDF]
Monteiro S +5 more
europepmc +1 more source
ABSTRACT Background Daratumumab is widely used in relapsed/refractory multiple myeloma, but ocular adverse events are rare and not well‐characterized. Case Presentation A 68‐year‐old woman developed acute blurred vision during the second day of her first daratumumab infusion.
Metban Mastanzade +5 more
wiley +1 more source

